Mark A Hull

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Positive Breast Cancer

Randomized Controlled Trial

Top Venues

Nature reviews. Gastroenterology & hepatology

Cancer chemotherapy and pharmacology

The Proceedings of the Nutrition Society

This page only lists publications with an associated author ORCID identifier.

Publications

Suparna Mitra, Christopher J Stewart, Andrew Nelson, James S Hampton, Andrea C Masi, Sarah Manning, Linda Sharp, Mark A Hull, Colin J Rees
Long-term stability of the faecal microbiome profile in faecal immunochemical test (FIT) samples. Gut (2024)
Suparna Mitra, Christopher J Stewart, Andrew Nelson, James S Hampton, Andrea C Masi, Sarah Manning, Linda Sharp, Mark A Hull, Colin J Rees
Long-term stability of the faecal microbiome profile in faecal immunochemical test (FIT) samples. Gut (2024)
John R Davies, Tracey Mell, Harriett Fuller, Mark Harland, Rasha Noureldin M Saleh, Amanda D Race, Colin J Rees, Louise C Brown, Paul M Loadman, Amy Downing, Anne Marie Minihane, Elizabeth A Williams, Mark A Hull
Polymorphisms in Cyclooxygenase, Lipoxygenase and TP53 genes predict colorectal polyp risk reduction by aspirin in the seAFOod polyp prevention trial. Cancer prevention research (Philadelphia, Pa.) (2023)
Amy Downing, Hayley Fenton, Claire Nickerson, Paul M Loadman, Elizabeth A Williams, Colin J Rees, Louise C Brown, Eva J A Morris, Mark A Hull
Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use. Alimentary pharmacology & therapeutics (2023)
Ge Sun, Harriett Fuller, Hayley Fenton, Amanda D Race, Amy Downing, Elizabeth A Williams, Colin J Rees, Louise C Brown, Paul M Loadman, Mark A Hull
The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E 2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International journal of cancer (2023)
Mark A Hull, Pei Loo Ow, Sharon Ruddock, Tim Brend, Alexandra F Smith, Helen Marshall, Mingyang Song, Andrew T Chan, Wendy S Garrett, Omer Yilmaz, David A Drew, Fiona Collinson, Andrew J Cockbain, Robert Jones, Paul M Loadman, Peter S Hall, Catherine Moriarty, David A Cairns, Giles J Toogood
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol. BMJ open 13 (11) (2023)
Joanna Aldoori, Andrew J Cockbain, Giles J Toogood, Mark A Hull
Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer. Gut 71 (4) (2022)
Milene Volpato, Michele Cummings, Abeer M Shaaban, Balkees Abderrahman, Mark A Hull, Philipp Y Maximov, Bradley M Broom, Reiner Hoppe, Ping Fan, Hiltrud B Brauch, V Craig Jordan, Valerie Speirs
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer. Exploration of targeted anti-tumor therapy 1 (2020)
Andrea C Masi, Sara Koo, Christopher Andrew Lamb, Mark A Hull, Linda Sharp, Andrew Nelson, James S Hampton, Colin J Rees, Christopher J Stewart
Using faecal immunochemical test (FIT) undertaken in a national screening programme for large-scale gut microbiota analysis. Gut 70 (2) (2020)
Mark A Hull
Nutritional prevention of colorectal cancer. The Proceedings of the Nutrition Society 80 (1) (2020)
Milene Volpato, Nicola Ingram, Sarah L Perry, Jade Spencer, Amanda D Race, Catriona Marshall, John M Hutchinson, Anna Nicolaou, Paul M Loadman, P Louise Coletta, Mark A Hull
Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer chemotherapy and pharmacology (2020)
Mark A Hull, Colin J Rees, Linda Sharp, Sara Koo
A risk-stratified approach to colorectal cancer prevention and diagnosis. Nature reviews. Gastroenterology & hepatology 17 (12) (2020)
Milene Volpato, Nicola Ingram, Sarah L Perry, Jade Spencer, Amanda D Race, Catriona Marshall, John M Hutchinson, Anna Nicolaou, Paul M Loadman, P Louise Coletta, Mark A Hull
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer chemotherapy and pharmacology 87 (2) (2020)
Mark A Hull, Sheraz R Markar, Eva J A Morris
Cancer risk after bariatric surgery - is colorectal cancer a special case? Nature reviews. Gastroenterology & hepatology 15 (11) (2019)
Henry Watson, Suparna Mitra, Fiona C Croden, Morag Taylor, Henry M Wood, Sarah L Perry, Jade A Spencer, Phil Quirke, Giles J Toogood, Clare L Lawton, Louise Dye, Paul M Loadman, Mark A Hull
A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut 67 (11) (2017)
Mark Lawler, Deborah Alsina, Richard A Adams, Annie S Anderson, Gina Brown, Nicola S Fearnhead, Stephen W Fenwick, Stephen P Halloran, Daniel Hochhauser, Mark A Hull, Viktor H Koelzer, Angus G K McNair, Kevin J Monahan, Inke S Näthke, Christine Norton, Marco R Novelli, Robert J C Steele, Anne L Thomas, Lisa M Wilde, Richard H Wilson, Ian P M Tomlinson, null null
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut 67 (1) (2017)